REGN-1400
Product Specifications
Target
EGFR
Related Pathways
JAK/STAT signaling, Tyrosine Kinase/Adaptors, Angiogenesis
Bioactivity
REGN-1400 is a fully human monoclonal antibody inhibitor targeting ErbB3. By inhibiting ErbB3, REGN-1400 blocks associated signaling pathways to reduce tumor cell proliferation. It shows potential for research in solid tumors such as non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and squamous cell carcinoma of the head and neck (SCCHN) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2294707 1.0 µg DNA
ST4 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details 
LV703208 1.0 µg DNA
KGFLP1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
Sign In for Pricing
View Details 
bs-0938R-Biotin 100 µL
NKG2D Polyclonal Antibody, Biotin Conjugated
Sign In for Pricing
View Details